/주식/ISRG
ISRG

ISRG

USD

Intuitive Surgical Inc. Common Stock

$517.180-0.940 (-0.181%)

실시간 가격

Healthcare
Medical Instruments & Supplies
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$518.120

고가

$524.440

저가

$512.670

거래량

0.17M

기업 기본 정보

시가총액

185.4B

산업

Medical Instruments & Supplies

국가

United States

거래 통계

평균 거래량

2.26M

거래소

NMS

통화

USD

52주 범위

저가 $378.87현재가 $517.180고가 $616

AI 분석 리포트

마지막 업데이트: 2025년 4월 28일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

ISRG: Intuitive Surgical Inc. Common Stock - What's Happening and What to Watch

Stock Symbol: ISRG Generate Date: 2025-04-28 13:47:54

Let's break down what's been going on with Intuitive Surgical, the company behind those sophisticated robotic surgery systems. We'll look at the latest news buzz, how the stock price has been moving, and what some of the data points suggest might come next.

The Latest Buzz: Analysts Like the Company, But There's a Catch

Looking at the recent news, there's a clear pattern. Several big investment firms – Barclays, RBC Capital, Truist Securities, Piper Sandler, and Baird – all follow ISRG closely. The good news? They generally still like the company, keeping their ratings positive like "Overweight," "Outperform," or "Buy." This tells us they believe in Intuitive Surgical's long-term prospects and business strength.

However, here's the catch: almost all of them have lowered their price targets for the stock. A price target is basically what an analyst thinks the stock should be worth in the future. So, while they still think it's a good company, they see less immediate room for the stock price to climb than they did before.

Why the lower targets? The news points to a couple of things. One big factor mentioned is tariff concerns. Intuitive Surgical itself brought this up after beating expectations on its first-quarter earnings. Even though they made more money than Wall Street thought they would, the potential impact of tariffs on their business is a worry they highlighted. This seems to be the main reason analysts are dialing back their price forecasts a bit, despite the company's strong growth, new products coming out (like that new stapler cleared by the FDA), and a solid balance sheet (meaning they have a healthy financial foundation).

So, the news vibe is a bit mixed: fundamentally strong company with good products and growth, but facing some external headwinds like potential tariffs that are making analysts a little less aggressive on their price outlook.

Checking the Price Tag: A Recent Bounce After a Dip

Now, let's look at what the stock price itself has been doing over the last month or two. If you glance at the historical data, you'll see ISRG had a pretty rough time in March, taking a noticeable dip from its earlier levels around $560-$600 down into the $470s.

Since then, though, it's bounced back somewhat in April. The price has been trading in a tighter range lately, hovering around the $510 to $520 mark. As of today, it's sitting right in that area, around $516.

Comparing this to the AI's short-term prediction, the model suggests a slight downward nudge might be coming over the next couple of days (0.00% today, then -0.25% and -0.85%). This hints that the recent upward momentum might pause or see a small pullback very soon.

Putting It All Together: What Might This Mean?

Based on the news, the recent price action, and the AI's short-term view, what's the picture?

The underlying sentiment from analysts is still positive on the company itself, which is a good sign. They like the business. But the tariff issue is a real concern that's causing them to be more conservative on the stock's immediate potential. The price has recovered from its March lows, showing some resilience, but the AI is forecasting a small dip right around the corner.

This combination seems to suggest a 'hold' or 'watch' stance might be reasonable right now, especially if you're already holding shares. The positive long-term view is there, but the immediate future has some question marks (tariffs) and the AI sees a slight pullback coming.

If you were thinking about potentially buying in, the AI prediction of a slight dip, combined with the recommendation data pointing to potential entry areas around $511-$514, might suggest waiting to see if the price softens a little could be one approach. Those levels are just below where the stock is trading now and fall within the recent consolidation range.

For managing risk, the recommendation data offers some potential levels to consider. A stop-loss around $488.47 is suggested. This level is below the recent trading range and significantly below the March lows, acting as a point to potentially limit losses if the stock takes a bigger downturn. On the flip side, a take-profit level around $525.21 is mentioned. This is near the recent highs and could be a point to consider locking in gains if the stock pushes up slightly from here.

A Quick Look at the Company

Remember, Intuitive Surgical is a leader in robotic surgery. This is a specialized, high-tech field. Their success is tied to the adoption of these advanced surgical systems by hospitals and doctors. Because it's a growth-oriented tech/healthcare company, it trades at a high valuation (that P/E ratio of 65.65 is quite high compared to many companies), meaning investors expect strong growth to continue. The tariff issue is particularly relevant because it could impact the cost or accessibility of their systems globally.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

관련 뉴스

GlobeNewswire

Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection

SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and

더 보기
Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local  Excision/Resection
Analyst Upgrades

Barclays Maintains Overweight on Intuitive Surgical, Lowers Price Target to $635

Barclays analyst Matt Miksic maintains Intuitive Surgical with a Overweight and lowers the price target from $684 to $635.

더 보기
Barclays Maintains Overweight on Intuitive Surgical, Lowers Price Target to $635
Analyst Upgrades

Analysts Remain Bullish On Intuitive Surgical Despite Macro Uncertainty

Intuitive Surgical's price target was cut to $590 on tariff concerns, but analysts remain positive on strong growth, new product cycle, and solid balance sheet.

더 보기
Analysts Remain Bullish On Intuitive Surgical Despite Macro Uncertainty
Analyst Upgrades

RBC Capital Maintains Outperform on Intuitive Surgical, Lowers Price Target to $605

RBC Capital analyst Shagun Singh maintains Intuitive Surgical with a Outperform and lowers the price target from $630 to $605.

더 보기
RBC Capital Maintains Outperform on Intuitive Surgical, Lowers Price Target to $605
Analyst Upgrades

Truist Securities Maintains Buy on Intuitive Surgical, Lowers Price Target to $590

Truist Securities analyst Richard Newitter maintains Intuitive Surgical with a Buy and lowers the price target from $605 to $590.

더 보기
Truist Securities Maintains Buy on Intuitive Surgical, Lowers Price Target to $590
Analyst Upgrades

Piper Sandler Maintains Overweight on Intuitive Surgical, Lowers Price Target to $575

Piper Sandler analyst Adam Maeder maintains Intuitive Surgical with a Overweight and lowers the price target from $670 to $575.

Analyst Upgrades

Evercore ISI Group Maintains In-Line on Intuitive Surgical, Lowers Price Target to $470

Evercore ISI Group analyst Vijay Kumar maintains Intuitive Surgical with a In-Line and lowers the price target from $510 to $470.

AI 예측Beta

AI 추천

약세

업데이트 시간: 2025년 5월 2일 오전 09:30

약세중립강세

56.3% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
보수적공격적
트레이딩 가이드

진입점

$517.06

익절

$527.46

손절

$493.61

핵심 요소

DMI는 약세 추세(ADX:14.4, +DI:3.7, -DI:6.8)를 보여 주의를 요합니다.
현재 가격이 지지선($518.47)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(27,646)의 3.2배로 극도로 강력한 매수 압력을 나타냅니다.
MACD 0.0371이(가) 신호선 0.3010 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기